Skip to main content

Table 2 Changes in CAT and mMRC scores from baseline to the end of the study period

From: Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: a prospective single-arm study

 

Baseline

(n = 36)

End

(n = 36)

P value

CAT

12.31 ± 7.79

4.39 ± 3.20

<  0.0001

mMRC

2.53 ± 1.48

1.17 ± 0.83

<  0.0001

  1. Data are presented as mean ± SD. The study period was 26 ± 2 weeks. Abbreviations: CAT chronic obstructive pulmonary disease assessment test, mMRC Modified Medical Research Council dyspnea scale
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us